Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: Analysis of the literature

Lung Cancer

Volumn 19, Issue 1, 1998, Pages 3-13

  Vansteenkiste, Johan F ^a   De Leyn, Paul R ^a   Deneffe, Georges J ^a   Lerut, Tony E ^a   Demedts, Maurits G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Carcinoma, non small cell lung; Lung neoplasms; Lymphatic metastasis; N2 disease; Neoplasms, mediastinum; Prognostic factors; Staging

Indexed keywords

ARTICLE; CANCER STAGING; HISTOLOGY; HUMAN; INFORMATION PROCESSING; LITERATURE; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; PEER REVIEW; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS;

EID: 18744432910     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00072-X     Document Type: Article

References (45)

1. Klastersky J., Burkes R., Choi N.C., Dombernowsky P., Darwish S., Ginsberg R.J., Gregor A., Ihde D., Kocha W., MacBeth F., Mirimanoff R., Mornex F., Nemec J., Opalka P., Payne D.G., Pujol J.L., Stout R., Van Zandwijk N. Induction therapy for NSCLC: a consensus report. Lung Cancer. 7:1991;15-17.
2. Goldstraw P., Mannam G., Kaplan D., Michael P. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg. 107:1994;19-28.
3. Martini N., Flehinger B. The role of surgery in N2 lung cancer. Surg Clin North Am. 67:1987;1037-1049.
4. Watanabe Y., Shimizu J., Oda M., Hayashi Y., Watanabe S., Tatsuzawa Y., Iwa T., Suzuki M., Takashima T. Aggressive surgical intervention in N2 non-small cell lung cancer of the lung. Ann Thorac Surg. 51:1991;253-261.
5. Vansteenkiste J.F., De Leyn P.R., Deneffe G.J., Stalpaert G., Nackaerts K.L., Lerut T.E., Demedts M.G. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases. The Leuven lung Cancer Group. Ann Thorac Surg. 63:1997;1441-1450.
6. Cybulski I., Lanza L., Bernadette R., Putnam J., McMurtrey M., Roth J. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg. 54:1992;533-537.
7. Frytak S., Eagan R., Sawamura K., Lee R., Pairolero P. Treatment of limited stage III non-small cell carcinoma of the lung. Cancer Invest. 6:1988;193-207.
8. Ishida T., Tateishi M., Kaneko S., Sugimachi K. Surgical treatment of patients with non-small cell lung cancer and mediastinal lymph node involvement. J Surg Oncol. 43:1990;161-166.
9. Kirsh M., Sloan H. Mediastinal metastases in bronchogenic carcinoma: Influence of postoperative irradiation, cell type, and location. Ann Thorac Surg. 33:1982;459-463.
10. Maggi G. Results of radical treatment of stage IIIa non-small cell carcinoma of the lung. Eur J Cardiothorac Surg. 2:1988;329-335.
11. Mountain C.F. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer. 73:1994;2589-2598.
12. Naruke T., Goya T., Tsuchiya R., Suemasu K. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg. 46:1988;603-610.
13. Patterson G.A., Piazza D., Pearson F., Todd T., Ginsberg R.J., Goldberg M., Waters P., Jones D., Ilves R., Cooper J. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg. 43:1987;155-159.
14. Pearson F., DeLarue N., Ilves R., Todd T., Cooper J. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg. 83:1982;1-11.
15. Regnard J., Magdeleinat P., Azoulay D., Dartevelle P., Deneuville M., Rojas-Miranda A., Levasseur P. Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients. Eur J Cardiothorac Surg. 5:1991;583-587.
16. Roeslin N., Warter A., Gasser B., Chafke N., Weil G., Dumont P., Wihlm J.M., Morand G., Witz J.P. Cancers bronchiques non anaplasiques, N2, opérés. Evaluation multifactorielle du pronostic. Ann Chir. 45:1991;673-678.
17. Suemasu K., Naruke T. Prognostic significance of extranodal cancer invasion of mediastinal lymph nodes in lung cancer. Jpn J Clin Oncol. 12:1982;207-212.
18. Thomas P., Piantadosi S., Mountain C.F. Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg. 95:1988;883-887.
19. Van Klaveren R., Festen J., Otten H., Cox A., de Graaf R., Lacquet L. Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer. Ann Thorac Surg. 56:1993;300-304.
20. Cox D.R. Regression models and life tables. J R Stat Soc Biol. 34:1972;187-198.
21. Coughlin M., Deslauriers J., Beaulieu M., Fournier B., Piraux M., Rouleau J., Tardif A. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg. 40:1985;556-560.
22. Funatsu T., Matsubara Y., Hatakenaka R., Kosaba S., Yasuda Y., Ikeda S. The role of mediastinoscopy biopsy in preoperative assessment of lung cancer. J Thorac Cardiovasc Surg. 104:1992;1688-1695.
23. Ratto G.B., Mereu C., Motta G. The prognostic significance of preoperative assessment of mediastinal lymph nodes in patients with lung cancer. Chest. 93:1988;807-813.
24. World Health Organization Histological typing of lung tumors, 2nd ed. Am J Clin Pathol. 77:1982;123-136.
25. Naruke T., Suemasu K., Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Surg. 76:1978;832-837.
26. Mountain C.F. Staging of lung cancer: The new international system. Lung Cancer. 3:1987;4-11.
27. Shepherd F.A. Induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac Surg. 55:1993;1585-1592.
28. Dillemans B., Deneffe G., Verschakelen J., Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardiothorac Surg. 8:1994;37-42.
29. Jolly P.C., Hutchinson C.H., Detterbeck F., Guyton S.W., Hofer B., Anderson R.P. Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer. J Thorac Cardiovasc Surg. 102:1991;266-271.
30. Libshitz H.I., McKenna R.J., Mountain C.F. Patterns of mediastinal metastases in bronchogenic carcinoma. Chest. 90:1986;229-232.
31. Feld R., Rubinstein L., Weisenburger T. Lung Cancer Study Group. Sites of recurrence in resected stage I non-small-cell lung cancer: A guide for future studies. J Clin Oncol. 2:1984;1352-1358.
32. Ferrigno D. Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer. Chest. 106:1994;1025-1029.
33. Deneffe G., Lacquet L., Verbeken E., Vermaut G. Surgical treatment of bronchogenic carcinoma: a retrospective study of 720 thoracotomies. Ann Thorac Surg. 45:1988;380-383.
34. Shields T.W., Humphrey E., Minneapolis M., Matthews M. Pathological stage grouping of patients with resected carcinoma of the lung. J Thorac Cardiovasc Surg. 80:1980;400-405.
35. Bulzebruck H., Drings P., Kayser K., Shulz V., Tuengerthal S., Vogt-Moykopf I. Classification of lung cancer: First experiences with the new TNM classification. Eur Respir J. 4:1991;1197-1206.
36. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 96:1988;440-447.
37. Bonnadonna G. Evolving concepts in the systemic adjuvant treatment of breast cancer. Cancer Res. 52:1992;2127-2137.
38. Nohl-Oser H.C. An investigation of the anatomy of the lymphatic drainage of the lungs as shown by the lymphatic spread of bronchial carcinoma. Ann R Coll Surg Engl. 51:1972;157-176.
39. Warren M.F., Drinker C.K. Flow of lymph from lungs of the dog. Am J Physiol. 136:1942;207-221.
40. Rouviere, H. Anatomie des lymphatiques de l'homme. Paris: Masson, 1932.
41. Bignall J.R., Moon A.J. Survival after lung resection for bronchogenic carcinoma. Thorax. 10:1955;183-186.
42. Paulson D.L. Selection of patients for surgery of bronchogenic carcinoma. Am Surg. 39:1973;1-9.
43. Theunissen P.H., Bollen E.C., Koudstaal J., Thunnissen F.B. Intranodal and extranodal tumour growth in early metastasised non-small cell lung cancer: problems in histological diagnosis. J Clin Pathol. 47:1994;920-923.
44. Rhoads A.C., Thomas J.H., Hermreck A.S., Pierce G.E. Comparative studies of computerized tomography and mediastinoscopy for the staging of bronchogenic carcinoma. Am J Surg. 152:1986;587-591.
45. Shields T.W. The significance of ipsilateral mediastinal lymph node metastasis in non small cell lung cancer. J Thorac Cardiovasc Surg. 99:1990;48-53.